Dr. Frank Roman Avilucea, MD

Dr. Avilucea practices at Orlando Health Physician Group Inc in Orlando, Florida.

Dr. Avilucea's NPI, 1548403389, was assigned on April 9, 2009. Dr. Avilucea graduated from The University of New Mexico School of Medicine in 2009. Dr. Avilucea holds Florida license ME135022.

Dr. Avilucea's primary practice is Orlando Health Physician Group Inc, at 1222 S Orange Ave, Orlando, FL 32806 in Orange County. The practice phone is (321) 843-4690.

Dr. Avilucea's primary practice is Orlando Health Physician Group Inc in Orlando, Florida. Dr. Avilucea is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Avilucea to 2 more hospitals, 3 group practices and clinics, 3 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Avilucea practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic trauma is Dr. Avilucea's primary specialty in the NPI Registry, under taxonomy code 207XX0801X. Dr. Avilucea is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Avilucea's licenses on file in 4 states: Florida, Tennessee, Ohio and Utah.

Dmand AI lists arthritis, bursitis, hip replacement, joint or bone infection, joint pain, knee arthroscopy, knee injury and knee replacement among the conditions Dr. Avilucea treats.

CMS data shows 1,496 Medicare services from Dr. Avilucea across 18 procedure codes in 2024, for 347 Medicare patients. Medicare paid $125,409 for them.

CMS counts 347 Medicare patients who saw Dr. Avilucea in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have arthritis, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Avilucea's median patient age at 71, with 64% women.

In 2024, Dr. Avilucea wrote 227 Medicare Part D claims for 137 patients. 96% of them were for generic drugs. CMS names the drug for 151 of them, across 6 drugs with 11 or more claims each, at $901 in total drug cost. In 2023, CMS named 109 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Avilucea for performance year 2024, reported as part of a group. Dr. Avilucea accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of hip replacement by Dr. Avilucea, more than 90% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 50 papers to Dr. Avilucea, published from 2010 to 2023. 2023 was the busiest year, with 5. The most frequent topics are Fractures, Bone, Fracture Fixation, Intramedullary and Acetabulum. Dr. Avilucea has published most often in J Orthop Trauma. Dr. Avilucea's most frequent co-authors are Michael T. Archdeacon, MD, George John Haidukewych, MD and Hassan Riaz Mir, MD.

CMS Open Payments shows 531 general payments to Dr. Avilucea from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Zimmer Biomet Holdings, Inc. paid the most, $136,389.

Dr. Avilucea graduated from The University of New Mexico School of Medicine in 2009.

Dr. Avilucea is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.